Biopharmaceutical Innovation and Access: Incenting Appropriate Utilization

NEHI’s policy agenda is embedded in the projects it pursues. These are driven primarily by its members. But NEHI’s access to policy makers, patient advocacy groups, and other key stakeholders help it shape projects as well. The projects identified seek to strike a balance between work that address well defined, immediate issues, and those that, because of their complexity, require extended dissection and analysis, and the iteration of solutions over time.

Filter Initiatives By Theme:

Initiatives

Showing : 1–10 of 30

Publication Date: March 26, 2020

Unlocking the Unrealized Potential of Adult Immunization: A NEHI Policy Brief

Adult immunization – one of the most highly effective of evidence-based services – must be a high priority. These recommendations will require effort and careful consideration of, among other things, how increased costs should be apportioned between health insurance plans and other sources of public and private payment. Nevertheless, we have solved far greater challenges. We can not continue to push this issue into the future.
View More
Publication Date: March 5, 2019

Next Generation Therapies in Massachusetts: New Solutions for Coverage and Payment

NEHI white paper urges early assessment of trends in the drug development pipeline to identify needed changes in coverage and payment policies, and identifies five principles of cross-industry collaboration that should shape new policies.
View More
Publication Date: October 24, 2017

Value-Based Contracting for Oncology Drugs: A NEHI White Paper

NEHI white paper calls for a series of regulatory steps and other actions to enable new payment arrangements for high cost cancer drugs.
View More
Publication Date: March 23, 2017

Rewarding Results: Moving Forward on Value-Based Contracting for Biopharmaceuticals

NEHI's findings on one promising approach to managing biopharmaceutical costs
View More
Publication Date: September 8, 2016

Better Use of Medicines for Diabetes Patients

NEHI report outlines the challenges presented by medication use in diabetes and provides five innovative solutions to improve diabetes care
View More
Publication Date: June 28, 2016

Accelerated Pathways Work; Now What?

A survey of payer opinions of products that have gone through US FDA expedited pathways from NEHI and PAREXEL.
View More
Publication Date: June 9, 2016

Maximizing the Potential of Real World Evidence to Support Health Care Innovation

NEHI's Recommendations to Strengthen a Culture of RWE That Will Make Health Care Innovation Thrive.
View More
Publication Date: February 11, 2016

Delivering Medical Innovation in a Value-Based World

As accountable care organizations, bundled payments and other value-based payment models sweep the nation, NEHI works to uncover implications for innovation.
View More
Publication Date: September 22, 2015

Real World Evidence: A New Era for Health Care Innovation

An issue brief on the major challenges and opportunities for Real World Evidence to reach its full potential
View More
Publication Date: November 13, 2014

A Bundle of Potential and Risk: Bundled Payment and its Impact on Innovation

This Issue Brief reflects findings from the event, in addition to background research and expert interviews conducted by NEHI on what this changing landscape means for patient access to innovative therapies and medical devices.
View More